NCT07781852 Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07780968 Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA Status NOT_YET_RECRUITING Phase N/A
NCT07780721 Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07775859 NOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal Cancers Status NOT_YET_RECRUITING Phase N/A
NCT07770672 An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging Status NOT_YET_RECRUITING Phase PHASE2
NCT07770100 Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) Status NOT_YET_RECRUITING Phase PHASE2
NCT07757022 AI-Driven Digital Twin and Drug Simulation for Esophageal Cancer Status NOT_YET_RECRUITING Phase N/A
NCT07752875 A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07733830 Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC Status RECRUITING Phase PHASE2
NCT07685938 Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease Status NOT_YET_RECRUITING Phase PHASE2
NCT07642401 Large-scale Models of Esophageal Cancer and Related Research Status ENROLLING_BY_INVITATION Phase N/A
NCT07578571 A Phase 1 Study of IM-1617 in Participants With Advanced Cancer Status RECRUITING Phase PHASE1
NCT07549269 Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis Status COMPLETED Phase N/A
NCT07431281 Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 Status RECRUITING Phase PHASE3
NCT07367516 Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer Status RECRUITING Phase PHASE1/PHASE2